13F Data
13F filer · CIK 1697013

Eversept Partners, LP

NEW YORK, NY · filing since Q4 2017 · last filing Aug 14, 2026
Reported value
$1.9B
+$31.2M vs prior
Positions
120
New / sold out
32 / 32
Added / reduced
40 / 41
Turnover
29.6%
buys $565.3M · sells $731.4M
Top-10 weight
45.7%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedENSIGN GROUP INC+587,318+3978.8%+$94.1M
AddedENCOMPASS HEALTH CORP+832,815+429.1%+$84.2M
NewCARETRUST REIT INC+1,072,015–+$43.3M
NewUNITEDHEALTH GROUP INC+51,145–+$21.3M
NewCOGENT BIOSCIENCES INC+490,235–+$19.0M
NewINSMED INC+149,209–+$15.9M
AddedTENET HEALTHCARE CORP+84,687+287.0%+$15.8M
AddedTRAVERE THERAPEUTICS INC+256,363+47.2%+$14.6M
AddedVIKING THERAPEUTICS INC+363,812+152.2%+$14.2M
NewAMN HEALTHCARE SVCS INC+428,531–+$13.9M
62 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedINVESCO QQQ TRPUT-140,100-58.7%$-103.2M
Sold outSPYSTATE STR SPDR S&P 500 ETF TPUT-107,000-100.0%$-69.6M
ReducedGSK PLC-1,303,342-73.0%$-68.3M
ReducedNATERA INC-208,906-54.3%$-56.7M
Sold outVERTEX PHARMACEUTICALS INCCALL-90,000-100.0%$-40.2M
Sold outISHARES TRPUT-428,800-100.0%$-37.2M
Sold outHEALTHPEAK PROPERTIES INC-1,981,070-100.0%$-32.5M
Sold outAVANTOR INC-2,974,287-100.0%$-23.3M
Sold outQIAGEN NV-545,330-100.0%$-21.8M
ReducedWELLTOWER INC-93,641-51.7%$-21.3M
63 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2017: $173.8MQ1 2018: $215.3MQ2 2018: $218.6MQ3 2018: $227.9MQ4 2018: $184.7MQ1 2019: $342.8MQ2 2019: $357.1MQ3 2019: $322.4MQ4 2019: $566.3MQ1 2020: $402.3MQ2 2020: $729.3MQ3 2020: $450.1MQ4 2020: $852.5MQ1 2021: $1.3BQ2 2021: $1.5BQ3 2021: $1.4BQ4 2021: $1.6BQ1 2022: $1.3BQ2 2022: $1.4BQ3 2022: $1.2BQ4 2022: $1.1BQ1 2023: $1.4BQ2 2023: $1.2BQ3 2023: $1.2BQ4 2023: $1.1BQ1 2024: $1.5BQ2 2024: $1.5BQ3 2024: $1.5BQ4 2024: $1.1BQ1 2025: $984.7MQ2 2025: $1.1BQ3 2025: $1.5BQ4 2025: $2.0BQ1 2026: $1.9BQ2 2026: $1.9B
Q4 2017Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1UNITED THERAPEUTICS CORP DELCOM287,668$155.9M8.09%
2ABIVAX SASPONSORED ADS913,880$121.8M6.32%
3ENCOMPASS HEALTH CORPCOM1,026,919$103.8M5.38%
4ENSIGN GROUP INCCOM602,079$96.5M5.01%
5VERA THERAPEUTICS INCCL A2,212,770$94.9M4.93%
6INVESCO QQQ TRPUTUNIT SER 198,600$72.6M3.77%
7CELLDEX THERAPEUTICS INC NEWCOM NEW1,785,941$66.5M3.45%
8SYNDAX PHARMACEUTICALS INCCOM2,798,210$61.2M3.17%
9BROOKDALE SR LIVING INCCOM3,396,470$54.6M2.84%
10IONIS PHARMACEUTICALS INCCOM664,684$52.7M2.73%
110 more rows. Subscribe for $29/month to see every row, download the data and use the API.